FDA

23andMe Receives FDA Clearance for Genetic Health Risk report that looks at a Hereditary Colorectal Cancer Syndrome

January 22, 2019
23andMe received FDA clearance to report on the two most common genetic variants influencing what is called MUTYH-associated polyposis (MAP), a hereditary colorectal cancer syndrome.This new clearance is part of...
Read More

23andMe: Five Things from 2018

December 30, 2018
Before we kick off the New Year, let’s look back and highlight a few important moments for us here at 23andMe in 2018.The Power of Big DataFor some types of...
Read More

23andMe Granted The First and Only FDA Authorization For Direct-to-Consumer Pharmacogenetics Reports

October 31, 2018
The U.S. Food and Drug Administration (FDA) granted 23andMe authorization to offer reports to customers on pharmacogenetics, indicating how customers’ genetics may influence the way they metabolize certain medications.
Read More

23andMe’s Newest Genetic Health Risk Report

May 31, 2018
23andMe's new G6PD Deficiency* report provides information on whether a customer has a variant called Val68Met, which can lead to defects in an enzyme called glucose-6-phosphate dehydrogenase, or G6PD, that is associated with a form of anemia.
Read More

Learn More About 23andMe’s New Genetic Health Risk Reports

May 19, 2017
23andMe recently started offering customers new Genetic Health Risk reports that have received FDA authorization. Below we’ve highlighted some important features in these reports to help you get more out...
Read More

The FDA Wants To Hear Your Opinion

February 05, 2016
If you have an opinion about genetic testing and the best way to return those results, the U.S. Food and Drug Administration (FDA) wants to hear it at a daylong...
Read More

This Year’s Top Ten Stories in Genetics

December 28, 2015
Starting in January with the launch of the ambitious Precision Medicine Initiative in the United States, 2015 finished with a heated debate around the appropriate use of technology that allows...
Read More

A New 23andMe Experience

October 21, 2015
23andMe made some news today, with the launch of a new experience for customers that includes the first and only direct-to-consumer genetic service that meets U.S. FDA standards. We invested nearly...
Read More

Patients Perspective on Parkinson’s Disease

October 06, 2015
As federal regulators listened, patients told them of their symptoms – the sleepless nights, the days with uncontrollable tremors or the little struggles simply maintaining their balance. Paul Cannon, 23andMe’s...
Read More

Live Long And Prosper

September 25, 2015
We all measure our age in years, but results of a study lead by researchers at Kings College in London found what may be a better measurement of age –...
Read More